Airlift Bioreactors Market Report 2026

The airlift bioreactors market size has grown strongly in recent years. It will grow from $4.32 billion in 2025 to $4.75 billion in 2026 at a compound annual growth rate (CAGR) of 10%. The growth in the historic period can be attributed to expansion of biopharmaceutical manufacturing capacity, increased use of microbial fermentation processes, growth in enzyme and biofuel production, rising adoption of disposable bioprocessing systems, advancements in large-scale cell culture techniques.

The airlift bioreactors market size is expected to see strong growth in the next few years. It will grow to $6.71 billion in 2030 at a compound annual growth rate (CAGR) of 9%. The growth in the forecast period can be attributed to increasing demand for biologics and vaccines, rising investments in sustainable bio-manufacturing, expansion of contract manufacturing services, growing focus on process intensification, increasing adoption of smart bioreactor control systems. Major trends in the forecast period include increasing adoption of single-use airlift bioreactor systems, rising demand for large-scale aerobic fermentation solutions, growing integration of advanced process monitoring sensors, expansion of modular and scalable bioreactor designs, enhanced focus on energy-efficient mixing mechanisms.

The rising demand for biopharmaceutical products is expected to drive growth in the airlift bioreactors market going forward. Biopharmaceutical products are therapeutic agents derived from living organisms or produced through biotechnological methods, including recombinant DNA technology, cell cultures, and monoclonal antibodies. Demand is growing due to advancements in cell culture technologies, the rising prevalence of chronic and age-related diseases, innovations in bioprocessing, and progress in genomics. Airlift bioreactors offer significant advantages in producing therapeutic proteins, monoclonal antibodies, and vaccines. For instance, in August 2023, the Alliance for Regenerative Medicine, a US-based non-profit organization, reported 2,760 cell, gene, and tissue-engineering therapeutic developers worldwide in Q1 2023, a 101% increase from 1,369 in Q1 2022. Therefore, growing demand for biopharmaceutical products is propelling the airlift bioreactors market.

Companies in the airlift bioreactor market are emphasizing cloud-integrated systems to improve process efficiency, automation, and remote monitoring. Cloud-integrated bioreactors combine physical equipment with real-time monitoring, automated controls, and AI-driven optimization, allowing bioprocess teams to manage experiments more precisely and efficiently. For example, in April 2025, Culture Biosciences, a US-based company supporting biotech process development in the cloud, launched the Stratyx 250, a mobile, cloud-integrated bioreactor. The system provides cart-based mobility for lab relocation, integrates Culture Console software for real-time monitoring and automation, and uses single-use technology to minimize cleaning and downtime. Stratyx 250 also leverages AI and machine learning to optimize bioprocesses, achieving 25% faster development timelines, 30% improved scale-up success, and a 16% reduction in total cost per run. It can be used with a Cytiva 250 mL consumable that replicates large-scale reactor conditions on a smaller platform, supporting efficient process development and faster optimization.

In September 2025, Morimatsu Group, a Japan-based engineering firm, acquired Bioengineering AG for an undisclosed amount. This acquisition enables Morimatsu to strengthen its airlift bioreactor capabilities by integrating Bioengineering’s bioreactor and fermentation technologies and expanding its advanced bioprocess equipment portfolio. Bioengineering AG is a Switzerland-based manufacturer of bioreactor and fermentation equipment, providing proven airlift and stirred-tank bioreactor systems for industrial and research applications.

Major companies operating in the airlift bioreactors market are Sartorius AG, Cytiva, Applikon Biotechnology B.V., Cellexus International Ltd, Bionet Innovación S.L., Solida Biotech GmbH, Belach Bioteknik AB, OmniBRx Biotechnologies Pvt. Ltd., Electrolab Biotech Ltd., LABOAO Instrument Equipment Co. Ltd., Bailun Biotechnology Co. Ltd., BioReactor Sciences Inc., Shree Biocare Solutions Pvt. Ltd., Lab1st Scientific Co. Ltd., Cedarstone Industry LLC, New Brunswick Scientific Co. Inc., Eppendorf AG, Kuhner AG, Thermo Fisher Scientific Inc., Lonza Group AG, ABEC Inc., Pierre Guérin SAS, Bioengineering AG.

North America was the largest region in the airlift bioreactor market in 2025. The regions covered in the airlift bioreactors market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the airlift bioreactors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The airlift bioreactor market consists of sales of stainless steel and glass airlift bioreactors, bioplastics, bioactive compounds, level sensors. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.